Disruption of hepatic CD36 has been shown to reduce both lipid content and free fatty acid uptake in the liver of HFD-fed mice, and also to protect against associated systemic inflammation and insulin resistance [52]. The gene discussed is CD36; the disease is Insulin resistance.